Webinar: Reducing Latino Cancer Health Inequities Through Research, Outreach, and Training

by

Webinar
Amelie Ramirez - UT Health San Antonio 1
Share On Social!

Dr. Amelie G. Ramirez, leader of Salud America! at UT Health San Antonio, will share insight on Latino cancer on a webinar from the National Cancer Institute’s Center for Cancer Research and its Office of Equity and Inclusion.

The webinar is set for 12 p.m. ET on Oct. 2, 2024, as part of Hispanic Heritage Month.

Ramirez NIH NCI webinarRamirez’s presentation is titled “Reducing Latino Cancer Health Inequities Through Research, Outreach, and Training.”

Register here for the webinar.

Dr. Ramirez & Her Latino Cancer and Education Research

Ramirez is an internationally recognized health disparities researcher at UT Health San Antonio.

Here, she is professor and chair of the Department of Population Health Sciences and director of the Institute for Health Promotion Research at UT Health San Antonio. She also is associate director of cancer outreach and engagement at the Mays Cancer Center.

Ramirez conducts research to reduce Latino cancer disparities.

She aims to reduce lung cancer with Quitxt. This bilingual text-message service helps Latino young adults quit smoking, funded by the Cancer Prevention and Research Institute of Texas.

Dr.-Amelie-Ramirez-scaled
Dr. Amelie G. Ramirez

On breast cancer, Ramirez is a Susan G. Komen Scholar. Her work has helped increase Latino cancer screening rates and early detection. She has proven how bicultural patient navigation can help Latina patients get more timely diagnosis and treatment after an abnormal mammogram and improve the survivorship journey.

Ramirez also recently launched the “Avanzando Equidad de Salud: Latino Cancer Health Equity Research Center.”

The center, supported by a 4-year, $4.08-million grant from the American Cancer Society, is a response to cancer inequities facing Latinos in South Texas. The center will unite South Texas research scholars and the community to reduce health disparities across the cancer care continuum by targeting social determinants of health that prevent Latinos from obtaining equitable care.

Another of her efforts is to improve Latino participation in clinical trials.

Ramirez is enabling Latinos to volunteer for cancer and Alzheimer’s clinical trials. She is highlighting open clinical trials, conducting webinars, and sharing stories of real Latino clinical trial participants. This work is supported by Genentech, a member of the Roche Group.

She also leads the South Texas site of the Avanzando Caminos study. The study aims to enroll 1,500 Latino cancer survivors in South Texas and 1,500 more in Miami to help unpack the social, cultural, behavioral, mental, biological, and medical influences on post-cancer life.

Ramirez also has trained/mentored more than 250 Latinos in health fields.

She leads the National Cancer Institute-funded Éxito! training program. This helps master’s-level students and professionals pursue a doctoral degree and cancer research career. Of 226 Éxito! trainees since 2011, over 27% have enrolled in or graduated from a doctoral program.

“We work hard to enable Latinos take the next steps from a master’s degree to get their doctoral degree and focus on careers in Latino cancer research and prevention,” Ramirez said.

Dr. Ramirez & Her Service, Recognition

Ramirez is an elected member of the National Academy of Medicine.

She also is a Susan G. Komen Scholar, is on the prize jury for the Fries Prize for Improving Health Award and the Elizabeth Fries Health Education Award, and is a past member of the National Advisory Council on Minority Health and Health Disparities of the National Institute on Minority Health and Health Disparities.

In Texas, she is on the San Antonio Mayor’s Fitness Council and is Past Board President of the The Academy of Medicine, Engineering and Science of Texas (TAMEST).

amelie ramirez health equity in 2014
Dr. Amelie G. Ramirez

Additional recognition includes:

Ramirez also created the Advancing the Science of Cancer in Latinos biennial conference series.

Launched in 2018 and continued in 2020, 2022, and 2024, the conference welcomes international researchers, physicians, community leaders, patient advocates, and more to tackle Latino cancer from prevention to treatment to survivorship.

Advancing the Science of Cancer in Latinos is a sanctuary where we can share research, experience, and action to translate basic research into clinical best practices, effective community interventions, and professional training programs to eliminate cancer disparities in Latinos,” Ramirez said.

In 2022, TV personality Oprah Winfrey selected Ramirez as a “Cycle Breaker” for her groundbreaking work to build health equity in the Latino community. Watch the episode featuring Ramirez!

Ramirez earned M.P.H. and Dr.P.H. degrees from UT Health Science Center at the Houston School of Public Health.

She is a native of Laredo, Texas.

Explore More:

Cancer, Clinical Trials

By The Numbers By The Numbers

142

Percent

Expected rise in Latino cancer cases in coming years

Share your thoughts